MedPath

ORAPHARMA

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:5

Trial Phases

2 Phases

Phase 3:4
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (80.0%)
Phase 4
1 (20.0%)

Arestin - Use in Subjects With Peri-Implantitis

Phase 3
Completed
Conditions
Peri-Implantitis
Interventions
First Posted Date
2012-02-27
Last Posted Date
2014-06-26
Lead Sponsor
OraPharma
Target Recruit Count
215
Registration Number
NCT01539564
Locations
🇺🇸

UCLA School of Dentistry - Oral and Maxillofacial Surgery, Los Angeles, California, United States

🇺🇸

University of Florida College of Dentistry, Gainsville, Florida, United States

🇺🇸

Georgia Regents University, Augusta, Georgia, United States

and more 9 locations

Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)

Phase 3
Completed
Conditions
Peri-Implantitis
Interventions
First Posted Date
2012-01-25
Last Posted Date
2015-08-26
Lead Sponsor
OraPharma
Target Recruit Count
208
Registration Number
NCT01517334
Locations
🇺🇸

University of Maryland, School of Dentistry, Baltimore, Maryland, United States

🇺🇸

Tufts University School of Dental Medicine, Boston, Massachusetts, United States

🇺🇸

University of Michigan - Michigan Center for Oral Health Research, Ann Arbor, Michigan, United States

and more 7 locations

Long-term Safety of Minocycline in Patients With Gum Disease

Phase 4
Completed
Conditions
Periodontitis
Interventions
First Posted Date
2008-04-29
Last Posted Date
2011-12-12
Lead Sponsor
OraPharma
Target Recruit Count
35
Registration Number
NCT00668746
Locations
🇺🇸

Forsyth Institute, Boston, Massachusetts, United States

Antibiotic Study for Dental Implants

Phase 3
Completed
Conditions
Periodontitis
Interventions
First Posted Date
2008-04-21
Last Posted Date
2011-12-12
Lead Sponsor
OraPharma
Target Recruit Count
44
Registration Number
NCT00662532
Locations
🇺🇸

JJCPPW Investigational Site, Seattle, Washington, United States

Effect of Adjunctive Treatment With Arestin on the Subgingival Microflora in Patients With Moderate to Advanced Periodontitis

Phase 3
Completed
Conditions
Periodontitis
First Posted Date
2006-09-04
Last Posted Date
2006-09-25
Lead Sponsor
OraPharma
Target Recruit Count
128
Registration Number
NCT00371332

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.